Vraylar 1.5 MG capsule 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FP1GX
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $26,367
Award facts
- Contract value 100% obligated
- $26,367.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Vraylar 1.5 mg capsules (30-count units) with a ceiling value of $26,367.10. This competitively awarded, non-set-aside delivery order utilizes firm fixed-price pricing and is scheduled for completion by December 12, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 and extending through December 2026.
As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen serves as a critical supplier to the Defense Health Agency and other federal healthcare systems. The company maintains an extensive portfolio of federal contract awards covering brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. Vraylar, a neurological treatment medication, represents one of many pharmaceutical products the company delivers through the DLA Medical Supply Chain to support military healthcare programs globally. The IDC vehicle under which this delivery order is issued demonstrates AmerisourceBergen's capability to meet federal procurement requirements and positions it as a key vendor within the Defense Logistics Agency's pharmaceutical procurement strategy.
Quick answers
Who was awarded contract SPE2DR26FP1GX?
SPE2DR26FP1GX was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 11, 2025.
How much is contract SPE2DR26FP1GX worth?
The government has obligated $26,367 on SPE2DR26FP1GX.
Is contract SPE2DR26FP1GX an order under another contract?
Yes. SPE2DR26FP1GX is a delivery order under SPE2DR25D3014, an indefinite delivery contract.
Was contract SPE2DR26FP1GX competed?
The extent of competition for SPE2DR26FP1GX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award